Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials - Top-Institutions - MDSpire

Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials

  • By

  • Melinda J. Gooderham

  • H. Chih-ho Hong

  • Charles Lynde

  • Yvette Miller-Monthrope

  • Vimal H. Prajapati

  • Julien Ringuet

  • Irina Turchin

  • Jensen Yeung

  • Kim A. Papp

  • July 14, 2026

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, NY

    Key Differentiators

    • Dermatology

  • #2

    Northwestern University Feinberg School of Medicine
    Northwestern University Feinberg School of Medicine

    Chicago, IL

    Key Differentiators

    • Dermatology

  • #3

    University of California San Diego
    University of California San Diego

    La Jolla, CA

    Key Differentiators

    • Dermatology

  • #4

    Huashan Hospital, Fudan University
    Huashan Hospital, Fudan University

    Shanghai, China

    Key Differentiators

    • Dermatology

  • #5

    International Eczema Council
    International Eczema Council

    N/A, N/A

    Key Differentiators

    • Dermatology

Original Source(s)

Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials

  • by Melinda J. Gooderham, H. Chih-ho Hong, Charles Lynde, Yvette Miller-Monthrope, Vimal H. Prajapati, Julien Ringuet, Irina Turchin, Jensen Yeung, Kim A. Papp

  • July 14, 2026

Related Content

Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)

Atopic Dermatitis Treatment Targets Defined

Consensus definitions for disease control in atopic dermatitis aim to standardize clinical trial end points and support treat-to-target strategies.

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.